Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Longeveron Inc. | Chief Executive Officer | Class A Common Stock | 278K | $523K | $1.88 | Oct 1, 2024 | Direct |
Longeveron Inc. | Chief Executive Officer | Common Stock, par value $0.001 per share | 89.8K | $48.5K | $0.54 | Mar 12, 2024 | Direct |
Akari Therapeutics Plc | Director | Stock Option (Right to Buy) | 5M | Jun 28, 2024 | Direct | ||
Longeveron Inc. | Chief Executive Officer | Stock Option (right to buy) | 28.8K | Aug 15, 2024 | Direct | ||
Longeveron Inc. | Chief Executive Officer | Warrant (right to buy) | 10.6K | Apr 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LGVN | Longeveron Inc. | Oct 1, 2024 | 1 | -$25.1K | 4 | Oct 3, 2024 | Chief Executive Officer |
LGVN | Longeveron Inc. | Aug 15, 2024 | 3 | -$96.6K | 4 | Aug 19, 2024 | Chief Executive Officer |
AKTX | Akari Therapeutics Plc | Jun 28, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
LGVN | Longeveron Inc. | Apr 11, 2024 | 2 | $26.3K | 4 | Apr 12, 2024 | Chief Executive Officer, Director |
LGVN | Longeveron Inc. | Mar 12, 2024 | 2 | -$17.7K | 4 | Mar 20, 2024 | Chief Executive Officer, Director |
LGVN | Longeveron Inc. | Jan 2, 2024 | 1 | -$6.76K | 4 | Jan 25, 2024 | Chief Executive Officer, Director |
AKTX | Akari Therapeutics Plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |
LGVN | Longeveron Inc. | Sep 12, 2023 | 9 | $29.8K | 4 | Sep 13, 2023 | Chief Executive Officer |
LGVN | Longeveron Inc. | Sep 1, 2023 | 1 | -$11.4K | 4 | Sep 6, 2023 | Chief Executive Officer |
LGVN | Longeveron Inc. | Aug 18, 2023 | 1 | -$13.9K | 4 | Aug 22, 2023 | Chief Executive Officer |
LGVN | Longeveron Inc. | Apr 5, 2023 | 1 | -$9.97K | 4 | Jul 17, 2023 | Chief Executive Officer |
LGVN | Longeveron Inc. | Mar 1, 2023 | 1 | $0 | 4 | Feb 2, 2024 | Chief Executive Officer |
LGVN | Longeveron Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Executive Officer |
LGVN | Longeveron Inc. | Mar 1, 2023 | 0 | $0 | 3 | Mar 2, 2023 | Chief Executive Officer |